Opinion
Video
Author(s):
In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis
1:06 Therapeutic innovations in psoriasis
6:55 Challenges with individualizing treatment
7:51 Selective mechanism of deucravacitinib (TYK2 inhibitor)
11:25 Clinical outcomes of deucravacitinib in psoriasis
15:38 Positioning deucravacitinib in the treatment algorithm
17:58 Deucravacitinib vs apremilast
21:41 Novel non-steroidal topicals- tapinarof and roflumilast
26:06 Efficacy and safety of novel topicals
32:13 Benefits of topicals with cross indications
33:55 Remittive effect of tapinarof
37:08 Summary of novel treatments in psoriasis
39:45 Personalizing psoriasis treatment